The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksANW.L Regulatory News (ANW)

  • There is currently no data for ANW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Aberdeen New Thai Inv T...

17 Dec 2018 12:22

RNS Number : 7069K
Aberdeen New Thai Inv Trust PLC
17 December 2018
 

 

London, UK, 17 December 2018

Edison issues review on Aberdeen New Thai Investment Trust (ANW)

Aberdeen New Thai Investment Trust (ANW) was launched in 1989 and is the only Thailand-focused investment trust listed in London. It aims to deliver a high level of long-term capital growth through investing in a relatively concentrated portfolio of quality companies, following a disciplined bottom-up approach. The Thai equity market has been relatively resilient this year compared to MSCI AC Asia ex-Japan and MSCI Emerging Markets, reflecting Thailand's solid economic fundamentals. The manager believes Thai companies are particularly well-placed to benefit from the fast-growing neighbouring economies of Cambodia, Laos, Myanmar and Vietnam, and ANW offers some indirect exposure to these markets. The trust has delivered strong absolute returns over the past 10 years; an annualised NAV total return of 20.5%. Recent returns, however, have lagged the benchmark and the shares have traded at a persistently wide discount to cum-income NAV. In May 2018, the board announced a package of changes to address these issues which, if successful, should support further narrowing of the discount.

 

ANW's current 12.4% discount to cum-income NAV is slightly below its three-year average of 15.6% and at the bottom of the 12.4% to 21.3% over this period. The board recently announced a package of changes aiming to improve returns to shareholders, without affecting the investment process. Should these be successful, there is scope for the discount to tighten further over time.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Helena Coles, +44 (0)20 3681 2522

Gavin Wood, +44 (0)20 3681 2503

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRATRBTTMBBBBLP
Date   Source Headline
24th Feb 202111:29 amRNSNet Asset Value(s)
23rd Feb 202112:13 pmRNSNet Asset Value(s)
22nd Feb 20212:52 pmRNSGearing disclosure
22nd Feb 202112:08 pmRNSNet Asset Value(s)
19th Feb 20213:49 pmRNSNet Asset Value(s)
18th Feb 202111:00 amRNSNet Asset Value(s)
17th Feb 202111:56 amRNSNet Asset Value(s)
16th Feb 202111:26 amRNSNet Asset Value(s)
15th Feb 202112:31 pmRNSGearing Disclosures
15th Feb 202111:22 amRNSNet Asset Value(s)
12th Feb 202111:39 amRNSNet Asset Value(s)
11th Feb 20214:18 pmRNSPortfolio disclosure
11th Feb 202111:37 amRNSNet Asset Value(s)
10th Feb 202110:46 amRNSNet Asset Value(s)
9th Feb 202111:01 amRNSNet Asset Value(s)
8th Feb 202112:52 pmRNSGearing disclosure
8th Feb 202111:19 amRNSNet Asset Value(s)
5th Feb 202111:33 amRNSNet Asset Value(s)
4th Feb 20213:01 pmRNSMonth End Net Asset Value(s)
4th Feb 202111:53 amRNSNet Asset Value(s)
3rd Feb 202111:03 amRNSNet Asset Value(s)
2nd Feb 20211:33 pmRNSNet Asset Value(s)
1st Feb 20212:41 pmRNSGearing disclosure
1st Feb 202110:21 amRNSTotal Voting Rights
1st Feb 20219:16 amRNSBlock listing Interim Review
1st Feb 20218:00 amRNSEdison review on Aberdeen New Thai Inv Trust (ANW)
29th Jan 20215:13 pmRNSTransaction in Own Shares
29th Jan 202112:32 pmRNSNet Asset Value(s)
28th Jan 20214:54 pmRNSTransaction in Own Shares
28th Jan 20214:22 pmRNSHolding(s) in Company
28th Jan 202111:40 amRNSNet Asset Value(s)
27th Jan 20215:04 pmRNSTransaction in Own Shares
27th Jan 202111:43 amRNSNet Asset Value(s)
26th Jan 20215:01 pmRNSTransaction in Own Shares
26th Jan 20211:00 pmRNSNet Asset Value(s)
25th Jan 20215:14 pmRNSTransaction in Own Shares
25th Jan 20212:33 pmRNSGearing disclosure
25th Jan 202112:33 pmRNSNet Asset Value(s)
22nd Jan 20215:01 pmRNSTransaction in Own Shares
22nd Jan 202111:42 amRNSNet Asset Value(s)
21st Jan 20214:57 pmRNSTransaction in Own Shares
21st Jan 202111:46 amRNSHolding(s) in Company
21st Jan 202111:38 amRNSNet Asset Value(s)
20th Jan 202111:00 amRNSNet Asset Value(s)
19th Jan 20214:58 pmRNSTransaction in Own Shares
19th Jan 202110:51 amRNSNet Asset Value(s)
18th Jan 202112:56 pmRNSGearing disclosure
18th Jan 202112:38 pmRNSNet Asset Value(s)
15th Jan 202111:46 amRNSNet Asset Value(s)
14th Jan 202111:40 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.